The risk of esophageal obstruction associated with an anti-allergy medication (Claritin-D® 24-Hour - Original formulation)

Pharmacoepidemiology and Drug Safety

Volumn 13, Issue 1, 2004, Pages 29-34

  Manda, Bharati ^a   Drinkard, Carol R ^a   Shatin, Deborah ^a   Graham, David J ^b  

^a Center for Health Care Policy and Evaluation   (United States)

^b CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

Adverse drug events; Anti allergy medication; Pharmacoepidemiology; Post marketing drug surveillance

Indexed keywords

ANTIALLERGIC AGENT; CLARITIN D; LORATADINE;

ADOLESCENT; ADULT; AGED; ALLERGIC RHINITIS; ARTICLE; CHILD; CONTROLLED STUDY; DATA ANALYSIS; DISEASE ASSOCIATION; ESOPHAGOSCOPY; ESOPHAGUS OBSTRUCTION; ESOPHAGUS RESECTION; FEMALE; HUMAN; INCIDENCE; INFANT; MAJOR CLINICAL STUDY; MALE; MANAGED CARE; MEDICAL RECORD; PRESCRIPTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; SUSTAINED RELEASE FORMULATION;

ADOLESCENT; ADULT; AGED; AIRWAY OBSTRUCTION; ANTI-ALLERGIC AGENTS; CHILD; DEGLUTITION; DELAYED-ACTION PREPARATIONS; DRUG COMBINATIONS; EPHEDRINE; ESOPHAGUS; FEMALE; HUMANS; LORATADINE; MALE; MEDICAL RECORDS; MIDDLE AGED; PRODUCT SURVEILLANCE, POSTMARKETING; RETROSPECTIVE STUDIES;

EID: 0742307185     PISSN: 10538569     EISSN: None     Source Type: Journal    
DOI: 10.1002/pds.816     Document Type: Article

References (4)

1. Farinas E, Honig P. Upper gastrointestinal obstruction associated with Claritin-D® 24-Hour extended release tablets. J Allergy Clin Immunol 1997; 100(3): 427-428.
2. Ransom JH. Esophageal retention of loratadine plus pseudoephedrine extended-release tablets (Claritin-D® 24-Hour). J Allergy Clin Immunol 1998; 101(2): 287-288.
3. Honig PK, Graham DJ, Jenkins JK. Identification and risk management of upper gastrointestinal obstruction caused by an antihistamine-decongestant product. (Abstract). Clin Pharm Ther 2000; 67: 89.
4. Lorber R. 'Dear Doctor', Important Prescribing Information, dated 7 December 1998. Internet Communication. http://www.fda.gov/medwatch/safety/1998/clarit.htm d[21 October 2002].